Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder



Get the latest updates from https://www.sandoz.com/rss/feeds/news/media-releases.xml directly as they happen.

Follow now 65 followers

Latest posts

Last updated almost 2 years ago

Applications for proposed first-of-a-kind multiple sclerosis biosimilar natalizumab accepted by US FDA and EMA

almost 2 years ago

Submission of proposed biosimilar supported by comprehensive package; aims to expand treatment...

Sandoz Supplemental Biologics License Application accepted by US FDA for biosimilar Hyrimoz® (adalimumab-adaz) high concentration formulation (HCF)

almost 2 years ago

Submission supported by comprehensive analytical data package and clinical Phase I pharmacokinetics...

Sandoz Application for proposed biosimilar adalimumab’s high concentration formulation accepted by EMA

almost 2 years ago

Submission supported by comprehensive analytical and clinical data from new Phase I...

Sandoz announces new global ‘Act4Biosimilars’ initiative, to improve patient access and increase adoption by at least 30% in 30+ countries by 2030

about 2 years ago

Multidisciplinary Steering Committee established to drive action includes patient advocacy leaders, healthcare...

Sandoz appoints new Board representative to global AMR Industry Alliance

about 2 years ago

Dr. Boumediene Soufi, global head of Sandoz AMR (antimicrobial resistance) program, to...

Sandoz launches first generic pirfenidone in US for patients with idiopathic pulmonary fibrosis, growing its respiratory portfolio

about 2 years ago

Pirfenidone is used to treat idiopathic pulmonary fibrosis (IPF),1 a progressive disease...

Sandoz launches generic brimonidine tartrate/timolol maleate eyedrop in US for patients with ocular hypertension, expanding leading ophthalmic portfolio

about 2 years ago

Brimonidine tartrate/timolol maleate combination eyedrop is used to treat elevated eye pressure...

Sandoz extends collaboration agreement to drive cutting-edge digital solutions in global fight against antimicrobial resistance (AMR)

about 2 years ago

Extending existing master services agreement with Ares Genetics, to develop digital platform...

Sandoz targets growth opportunities in respiratory and complex generics through acquisition of respiratory device company Coalesce

over 2 years ago

Sandoz gains significant capabilities and assets in medical and drug device development...